1. Stillman R.J. In Utero Exposure to Diethylstilbestrol: Adverse Effects on the Reproductive Tract and Reproductive Performance in Male and Female Offspring. Am J. Obstet. & Gynec. 142:902, April 1982.
2. Herbst A.L., Ulfelder H, Poskanzer D.C: Adenocarcinoma of the Vagina: Association of Maternal Stilbestrol therapy with Tumor Appearance in Young Women. N Engl J Med 1971; 284: 878-881.
3. Vang R. et al. Pseudoinfiltrative Tubal Metaplasia of the Endocervix: A Potential Form of In Utero Diethylstilbestrol Exposure-Related Adenosis Simulating Minimal Deviation Adenocarcinoma. International Journal of Gynecological Pathology. 24:391-398, October 2005.
4. Swan S.H. Intrauterine Exposure to Diethylstilbestrol: Long-term Effects in Humans. APMIS 108:793-804, 2000.
5. Kaufman R.H. et al. Upper Genital Tract Changes and Pregnancy Outcome in Offspring Exposed in Utero to Diethylstilbestrol. Am J. Obstet. Gynecol. 137:3: 299-308, June 1980.
6. Acien P and Acien M. Evidence-based management of recurrent miscarriages. Surgical management. In: Advances in Fertility and Reproductive Medicine, Proceedings of the 18th World Congress on Fertility and Sterility. 1266: 335-342, April 2004.
7. Hricak H. et al. Cervical Incompetence: Preliminary Evaluation with MR Imaging. Radiology. 174:821-826, March 1990.
8. Missmer S.A. et al. In Utero Exposures and the Incidence of Endometriosis. Fertility and Sterility. 82; 6:1501-1507, December 2004.
9. Haney A.F. et al. Diethylstilbestrol-Induced Upper Genital Tract Abnormalities. Fertility and Sterility 31; 2: 142-6, Feb. 1979.
10. Palmer J.R. et al. Infertility among Women Exposed Prenatally to Diethylstilbestrol. Am. J. Epidemiology. 154; 4: 316-21, 2001.
11. Salle B. et al. Transvaginal Ultrasound Studies of Vascular and Morphological Changes in Uteri Exposed to Diethylstilbestrol In Utero. Human Reproduction. 11; 11: 2531-2536, 1996.
12. Karande V.C. et al. Are Implantation and Pregnancy Outcome Impaired in DES Exposed Women after In Vitro Fertilization and Embryo Transfer? Fertility and Sterility. 54; 2: 287-91, August 1990.
13. Pal L et al. Outcome of IVF in DES-Exposed Daughters: Experience in the 90s. J Assist Reprod. and Genet. 14; 9: 513-7, 1997.
14. Kaufman R.H. et al. Continued Follow-up of Pregnancy Outcomes in Diethylstilbestrol-exposed Offspring. Obstetrics and Gynecology. 96;4: 483-9, October, 2000.
15. Probst A.M. and Hill J.A. Anatomic Factors Associated with Recurrent Pregnancy Loss. Seminars in Reproductive Medicine 18; 4: 341-50, 2000.
16. Sher G. and Fisch J.D. Vaginal Sildenafil (Viagra): A Preliminary Report of a Novel Method to Improve Uterine Artery Blood Flow and Endometrial Development in Patients Undergoing IVF. Human Reproduction 15; 4: 806-9, April 2000.
17. Ankum W.M. et al. Risk Factors for Ectopic Pregnancy: A Meta-analysis. Fertility and Sterility. 65; 6: 1093-1099, June 1996.
18. DeCherney A.H. et al. Structure and Function of the Fallopian Tubes Following Exposure to Diethylstilbestrol (DES) During Gestation. Fertility and Sterility. 36; 6: 741-745, December 1981.
19. Newbold R.R. et al. Developmentally Arrested Oviduct: A Structural and Functional Defect in Mice Following Prenatal Exposure to Diethylstilbestrol. Teratology. 27: 417-426, 1983.
20. Waggoner S.E. et al. Influence of in Utero Diethylstilbestrol Exposure on the Prognosis and Biologic Behavior of Vaginal Clear-cell Adenocarcinoma. Gynecologic Oncology. 55: 238-244, 1994.
21. Robboy S. J. et al. Atypical Vaginal Adenosis and Cervical Ectropion. Cancer. 54:869-875, September 1984.
22. Robboy S.J. et al. Normal Development of the Human Female Reproductive Tract and Alterations Resulting from Experimental Exposure to Diethylstilbestrol. Hum Pathol. 13:190-198, 1982.
23. Althuisius S.M. et al. Final Results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): Therapeutic Cerclage with Bed rest versus bed Rest Alone. Am J Obstet Gynecol. 185; 5: 1106-1112, November 2001.
24. Bhutta A.T. et al. Cognitive and Behavioral Outcomes of School-Aged Children Who Were Born Preterm. JAMA. 288; 6 728-736, 2002.
25. Palmer J.R. et al. Prenatal Diethylstilbestrol Exposure and Risk of Breast Cancer. Cancer Epidemiology, Biomarkers and Prevention. 15; 8: 1509-1514, August 2006.
26. Baird, D.D. and Newbold, R. Prenatal Diethylstilbestrol (DES) Exposure is Associated with Uterine Leiomyoma Development. Reproductive Toxicology. 20:81-84, 2005.
27. Hatch E.E. et al. Age at natural Menopause in Women Exposed to Diethylstilbestrol in Utero. Am. J. Epidemiol. 164:682-688, 2006.
28. Ways S.C. et al. Alterations in Immune Responsiveness in Women Exposed to Diethylstilbestrol in Utero. Fertility and Sterility. 48; 2: 193-197, August 1987.
29. Kurita et al. Roles of P63 in the Diethylstilbestrol-Induced cervicovaginal Adenosis. Development and Disease. 131; 7: 1639-1649, 2004.
30. Huang W. et al. Developmental Diethylstilbestrol Exposure Alters Genetic Pathways of Uterine Cytodifferentiation. Molecular Endocrinology. 19; 3: 669-681, March 2005.
31. Luna M. et al. Moderately Elevated Levels of Basal Follicle-Stimulating Hormone in Young Patients Predict Low Ovarian Response, But Should Not Be Used to Disqualify Patients from Attempting In Vitro Fertilization. Fertility and Sterility. 87; 4: 782-791, April 2007.